Woodline Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.41M | Sell |
500,995
-728,783
| -59% | -$10.8M | 0.04% | 487 |
|
|
2025
Q1 | $22M | Sell |
1,229,778
-884,278
| -42% | -$15.8M | 0.14% | 213 |
|
|
2024
Q4 | $36.8M | Sell |
2,114,056
-2,226,284
| -51% | -$38.8M | 0.25% | 124 |
|
|
2024
Q3 | $60.7M | Buy |
4,340,340
+3,063,462
| +240% | +$42.9M | 0.51% | 45 |
|
|
2024
Q2 | $10.5M | Buy |
+1,276,878
| New | +$10.5M | 0.1% | 240 |
|
|
2024
Q1 | – | Sell |
-636,621
| Closed | -$5.72M | – | 634 |
|
|
2023
Q4 | $5.72M | Sell |
636,621
-1,513,944
| -70% | -$13.6M | 0.06% | 301 |
|
|
2023
Q3 | $19.2M | Buy |
2,150,565
+1,110,269
| +107% | +$9.93M | 0.23% | 137 |
|
|
2023
Q2 | $16M | Sell |
1,040,296
-399,403
| -28% | -$6.13M | 0.19% | 159 |
|
|
2023
Q1 | $32.4M | Buy |
1,439,699
+1,342,791
| +1,386% | +$30.2M | 0.44% | 64 |
|
|
2022
Q4 | $2.04M | Sell |
96,908
-171,267
| -64% | -$3.6M | 0.03% | 471 |
|
|
2022
Q3 | $6.61M | Buy |
+268,175
| New | +$6.61M | 0.09% | 249 |
|
|
2021
Q4 | – | Sell |
-145,918
| Closed | -$3.54M | – | 791 |
|
|
2021
Q3 | $3.54M | Buy |
+145,918
| New | +$3.54M | 0.06% | 306 |
|
|
2020
Q1 | – | Sell |
-281,423
| Closed | -$4M | – | 172 |
|
|
2019
Q4 | $4M | Buy |
+281,423
| New | +$4M | 0.16% | 96 |
|